Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147

Qian Hou1, Xu Tang, Hanqiang Liu

  • 1Department of Traditional Chinese Medicine, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.

Cancer Science
|March 30, 2011
PubMed

Insights

Berberine, a plant alkaloid, kills liver cancer cells by triggering apoptosis and autophagy. It also reduces CD147 expression, a key factor in cancer cell survival, revealing a novel anti-tumor mechanism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Berberine exhibits anti-tumor properties in various cancer cells.
  • The precise molecular mechanisms of berberine's anti-cancer effects, particularly in liver cancer, remain unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms of berberine-induced cell death in human hepatoma carcinoma (HCC) cell lines.
  • To explore the role of CD147 in mediating berberine's anti-tumor effects.

Main Methods:

  • Treatment of HepG2 and SMMC7721 HCC cell lines with berberine.
  • Assessment of cell viability, apoptosis, and autophagy.
  • Analysis of CD147 expression levels and its impact on cell death.

Main Results:

  • Berberine inhibited HCC cell viability in a dose- and time-dependent manner.
  • Berberine induced cell death through apoptosis and autophagy.
  • Berberine downregulated CD147 expression in HCC cells, and CD147 overexpression reduced berberine-induced cell death.

Conclusions:

  • Berberine induces cell death in human hepatoma carcinoma cells via apoptosis and autophagy.
  • Downregulation of CD147 is a key mechanism through which berberine exerts its anti-tumor effects in HCC.
  • These findings suggest a novel therapeutic strategy targeting CD147 for liver cancer treatment.

Related Concept Videos